These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2510589

  • 1. Deprenyl suppresses the oxidant stress associated with increased dopamine turnover.
    Cohen G, Spina MB.
    Ann Neurol; 1989 Nov; 26(5):689-90. PubMed ID: 2510589
    [Abstract] [Full Text] [Related]

  • 2. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
    Zsilla G, Földi P, Held G, Székely AM, Knoll J.
    Pol J Pharmacol Pharm; 1986 Nov; 38(1):57-67. PubMed ID: 3020531
    [Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase and oxidative stress at dopaminergic synapses.
    Cohen G.
    J Neural Transm Suppl; 1990 Nov; 32():229-38. PubMed ID: 2128499
    [Abstract] [Full Text] [Related]

  • 4. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J.
    J Neural Transm Suppl; 1987 Nov; 25():45-66. PubMed ID: 2828537
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition.
    Harsing LG, Magyar K, Tekes K, Vizi ES, Knoll J.
    Pol J Pharmacol Pharm; 1979 Nov; 31(4):297-307. PubMed ID: 523338
    [Abstract] [Full Text] [Related]

  • 6. 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.
    Kitanaka J, Kitanaka N, Tatsuta T, Takemura M.
    Pharmacol Biochem Behav; 2005 Nov; 82(3):488-94. PubMed ID: 16298423
    [Abstract] [Full Text] [Related]

  • 7. The action of (-) deprenyl on monoamine turnover rate in rat brain.
    Zsilla G, Knoll J.
    Adv Biochem Psychopharmacol; 1982 Nov; 31():211-7. PubMed ID: 6805258
    [No Abstract] [Full Text] [Related]

  • 8. Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier.
    Wiener HL, Hashim A, Lajtha A, Sershen H.
    Eur J Pharmacol; 1989 Apr 12; 163(1):191-4. PubMed ID: 2501102
    [Abstract] [Full Text] [Related]

  • 9. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG, Vizi ES.
    Br J Pharmacol; 1984 Nov 12; 83(3):741-9. PubMed ID: 6439273
    [Abstract] [Full Text] [Related]

  • 10. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP, Lamensdorf I, Armoni T.
    Neurobiology (Bp); 2000 Nov 12; 8(2):137-42. PubMed ID: 11061211
    [Abstract] [Full Text] [Related]

  • 11. Irregular chronic stress related selective presynaptic adaptation of dopaminergic system in rat striatum: effects of (-)deprenyl and amitriptyline.
    Tekes K, Tothfalusi T, Magyar K.
    Acta Physiol Pharmacol Bulg; 1986 Nov 12; 12(4):21-8. PubMed ID: 3107343
    [Abstract] [Full Text] [Related]

  • 12. The pharmacology of (-)deprenyl.
    Knoll J.
    J Neural Transm Suppl; 1986 Nov 12; 22():75-89. PubMed ID: 3097262
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels.
    Steyn SJ, Castagnoli K, Steyn S, Castagnoli N.
    Exp Neurol; 2001 Apr 12; 168(2):434-6. PubMed ID: 11259132
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
    Pérez V, Morón J, Pastó M, Unzeta M.
    Neurobiology (Bp); 2000 Apr 12; 8(3-4):231-6. PubMed ID: 11225513
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
    Timár J, Yasar S, Knoll B, Knoll J.
    Acta Physiol Hung; 1990 Apr 12; 75 Suppl():279-80. PubMed ID: 2115233
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of Ca2+ in dopamine release in striatal rat slices by PF9601N and L-deprenyl.
    Pérez V, Pastó M, Unzeta M.
    Neurobiology (Bp); 2000 Apr 12; 8(3-4):237-42. PubMed ID: 11225514
    [Abstract] [Full Text] [Related]

  • 17. The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation.
    Oreland L, Arai Y, Stenström A.
    Acta Neurol Scand Suppl; 1983 Apr 12; 95():81-5. PubMed ID: 6428149
    [Abstract] [Full Text] [Related]

  • 18. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
    Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.
    Neurotoxicology; 2008 Mar 12; 29(2):244-58. PubMed ID: 18093658
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum.
    Vizuete ML, Steffen V, Ayala A, Cano J, Machado A.
    Neurosci Lett; 1993 Apr 02; 152(1-2):113-6. PubMed ID: 8515861
    [Abstract] [Full Text] [Related]

  • 20. L-deprenyl in prevention of MPTP induced depletion of striatal enkephalins in mice.
    Sheng JG, Xu DL, Yu HZ.
    Chin Med J (Engl); 1988 Apr 02; 101(4):292-4. PubMed ID: 3138091
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.